doxycycline hyclate 50 MG Oral Tablet

RxCUI
1652674
RxNorm name
doxycycline hyclate 50 MG Oral Tablet
Display name
Doxycycline (Oral Pill)
Full name
doxycycline hyclate 50 MG Oral Tablet
Term type
SCD
Status
Active
Strength
50 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-12 18:37:13

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072015
Active start
072015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
doxycycline hyclate50 MG / 1 EACHdoxycyclinedoxycycline

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
doxycycline3640

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
46708-499-6046708-499Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals LimitedANDA210536
62135-625-6062135-625Doxycycline Hyclate Doxycycline HyclateChartwell RX LLCANDA062505
62332-499-6062332-499Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals Inc.ANDA210536
64380-225-0164380-225DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATEStrides Pharma Science LimitedANDA062538
68999-625-6068999-625Doxycycline Hyclate Doxycycline HyclateChartwell Governmental & Specialty RX, LLCANDA062505
72143-262-6072143-262Doxycycline Hyclate Doxycycline HyclateJG Pharma Inc.ANDA062269

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA21053646708-499Doxycycline Hyclate Doxycycline HyclateANDAAlembic Pharmaceuticals Limited
ANDA06250562135-625Doxycycline Hyclate Doxycycline HyclateANDAChartwell RX LLC
ANDA06253864380-225DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATEANDAStrides Pharma Science Limited
ANDA06226972143-262Doxycycline Hyclate Doxycycline HyclateANDAJG Pharma Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 40 matching rows.

NDC11, Source, Active table
NDC11SourceActive
46708049960rxnav_ndcsyes
62135062560rxnav_ndcsyes
62332049960rxnav_ndcsyes
64380022501rxnav_ndcsyes
68999062560rxnav_ndcsyes
72143021160rxnav_ndcsyes
72143026260rxnav_ndcsyes
00185003601rxnav_historical_indirect
00185003605rxnav_historical_indirect
00196058302rxnav_historical_indirect
00378602101rxnav_historical_indirect
00378602105rxnav_historical_indirect
00527133501rxnav_historical_indirect
00779032215rxnav_historical_indirect
00879072450rxnav_historical_indirect
10337080001rxnav_historical_indirect
13411064003rxnav_historical_indirect
23155013301rxnav_historical_indirect
23155013305rxnav_historical_indirect
23155013311rxnav_historical_indirect
23155013330rxnav_historical_indirect
24658031160rxnav_historical
46193068705rxnav_historical_indirect
46193068706rxnav_historical_indirect
49884009101rxnav_historical_indirect
50090244608rxnav_historical
51079055720rxnav_historical_indirect
51079055741rxnav_historical_indirect
53261078907rxnav_historical_indirect
53261078908rxnav_historical_indirect
53261078909rxnav_historical_indirect
53261078910rxnav_historical_indirect
53261078912rxnav_historical_indirect
53261078913rxnav_historical_indirect
53261078914rxnav_historical_indirect
53261078920rxnav_historical_indirect
55700008628rxnav_historical_indirect
55700008630rxnav_historical_indirect
62436072801rxnav_historical_indirect
63304013010rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DoxycyclineDOXYCYCLINESun Pharmaceutical Industries Inc.8224b9c5-5c4b-4dda-bc58-47b6604c28842026-10-29Warnings, Adverse reactionsExact identifier
ndc11 (package): 63304013010
doxycyclineDOXYCYCLINEChartwell RX LLC3e7cf78f-3b48-4614-9fa4-c6d1e0c05a352026-10-16Warnings, Adverse reactionsExact identifier
ndc (package): 62135-625-60
ndc (product): 62135-625
ndc11 (package): 62135062560
rxcui: 1652674
Doxycycline HyclateDOXYCYCLINE HYCLATEAlembic Pharmaceuticals Inc.cff08863-7156-49d0-abbd-8f92743028862026-08-22Warnings, Adverse reactionsExact identifier
ndc (package): 62332-499-60
ndc (product): 62332-499
ndc11 (package): 62332049960
rxcui: 1652674
DOXYCYCLINE HYCLATEDOXYCYCLINE HYCLATEStrides Pharma Science Limited2deeee4f-b342-a178-e063-6394a90af8972026-06-26Warnings, Adverse reactionsExact identifier
ndc (package): 64380-225-01
ndc (product): 64380-225
ndc11 (package): 64380022501
rxcui: 1652674
TARGADOXDOXYCYCLINE HYCLATEJourney Medical Corporation83243f78-b984-46a4-a88a-c6a15c217b902025-10-21Warnings, Adverse reactionsExact identifier
rxcui: 1652674
doxycyclineDOXYCYCLINEChartwell Governmental & Specialty RX, LLCb8486639-7eb9-4610-9cd4-0e922045d5922025-09-30Warnings, Adverse reactionsExact identifier
ndc (package): 68999-625-60
ndc (product): 68999-625
ndc11 (package): 68999062560
rxcui: 1652674
Doxycycline HyclateDOXYCYCLINE HYCLATEJG Pharma Inc.10b8bf71-4311-41e8-a891-bab8bc86863f2025-08-01Warnings, Adverse reactionsExact identifier
ndc (package): 72143-262-60
ndc (product): 72143-262
ndc11 (package): 72143026260
rxcui: 1652674
DoxycyclineDOXYCYCLINEHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.2bcde264-5f6f-47f6-ae2e-1b7010deacf72025-07-18Warnings, Adverse reactionsExact identifier
ndc11 (package): 23155013311
ndc11 (package): 23155013301
ndc11 (package): 23155013330
ndc11 (package): 23155013305
DoxycyclineDOXYCYCLINELannett Company, Inc.4999bbd9-44ed-4749-9730-be2337bdf4902024-07-03Warnings, Adverse reactionsExact identifier
ndc11 (package): 00527133501
Doxycycline HyclateDOXYCYCLINE HYCLATEAlembic Pharmaceuticals Limited24c8472a-dd07-4f84-8bea-20a3f178d1192023-01-27Warnings, Adverse reactionsExact identifier
ndc (package): 46708-499-60
ndc (product): 46708-499
ndc11 (package): 46708049960
rxcui: 1652674

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8a9e1d08-1665-46d2-bda6-aa11a3f18646doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD]221Doxycycline Hyclate Tablets, USP20231121
3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD]216Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP20250930
cff08863-7156-49d0-abbd-8f9274302886doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD]212Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.20250830
b8486639-7eb9-4610-9cd4-0e922045d592doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD]210Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP20250930
83243f78-b984-46a4-a88a-c6a15c217b90doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD]27TARGADOX ® (doxycycline hyclate USP) 50 mg tablets20251021
24c8472a-dd07-4f84-8bea-20a3f178d119doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD]23Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.20230127
2deeee4f-b342-a178-e063-6394a90af897doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD]22Doxycycline Hyclate Tablets, USP20251120
10b8bf71-4311-41e8-a891-bab8bc86863fdoxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD]21Doxycycline Hyclate Tablets, USP 50 mg20250801

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
8224b9c5-5c4b-4dda-bc58-47b6604c2884DOXYCYCLINE TABLETS Rx onlySun Pharmaceutical Industries Inc. | Ohm Laboratories Inc. | Hovione PharmaScience Limited20261029
3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USPChartwell RX LLC20261016
3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USPChartwell RX LLC20260929
cff08863-7156-49d0-abbd-8f9274302886Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited20260822
2deeee4f-b342-a178-e063-6394a90af897Doxycycline Hyclate Tablets, USPStrides Pharma Science Limited | Strides Pharma International AG20260626
37a8cb92-0ade-4fbc-80f7-2ef283bc32cbDoxycycline Hyclate Tablets, USP 50 mgJG Pharma Inc. | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe20251212
2deeee4f-b342-a178-e063-6394a90af897Doxycycline Hyclate Tablets, USPStrides Pharma Science Limited | Strides Pharma Global Pte. Ltd.20251120
3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USPChartwell RX LLC20250930
b8486639-7eb9-4610-9cd4-0e922045d592Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USPChartwell Governmental & Specialty RX, LLC20250930
cff08863-7156-49d0-abbd-8f9274302886Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited20250830
10b8bf71-4311-41e8-a891-bab8bc86863fDoxycycline Hyclate Tablets, USP 50 mgJG Pharma Inc.20250801
2bcde264-5f6f-47f6-ae2e-1b7010deacf7DOXYCYCLINE TABLETS, USP Rx onlyHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | USV Private Limited20250718
4999bbd9-44ed-4749-9730-be2337bdf490Doxycycline Tablets, USPLannett Company, Inc.20240703
8a9e1d08-1665-46d2-bda6-aa11a3f18646Doxycycline Hyclate Tablets, USPPURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe20231121
24c8472a-dd07-4f84-8bea-20a3f178d119Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.Alembic Pharmaceuticals Limited20230127
e57b06c0-d0cd-41ff-9ca5-279b11c15e1cDoxycycline Hyclate Capsules, USP 50 mg and 100 mg Doxycycline Hyclate Tablets, USP 100 mgA-S Medication Solutions20210415
caa9928e-8cee-408c-ac72-bd6ce1390a70DOXYCYCLINE TABLETS, USP Rx onlyLake Erie Medical DBA Quality Care Products LLC20190425
8224b9c5-5c4b-4dda-bc58-47b6604c2884DOXYCYCLINE TABLETS Rx onlySun Pharmaceutical Industries Inc. | Ohm Laboratories Inc. | Hovione PharmaScience Limited20180806
86e1102c-47bc-4f27-a4d0-7261b3deba63Doxycycline Tablets, USPPar Pharmaceutical, Inc. | Par Pharmaceutical Inc.20170809
4ceb42f2-6585-4224-af3e-7d47ddfac5bbNational Council for Prescription Drug Programs20130213
eedd02ec-26d6-4dac-9ec9-8d86534bb961National Council for Prescription Drug Programs20120724
7c386618-89c6-4393-bf1b-80debf22f1a6National Council for Prescription Drug Programs20120724
f6d50e6b-084b-4298-8f3d-3ea28f03b8c2National Council for Prescription Drug Programs20120724
b34bad0e-583b-416b-adf4-e847edfc22ceNational Council for Prescription Drug Programs20120724
730d54e2-5cf3-4050-a6bb-a6d0302ceca8National Council for Prescription Drug Programs20120724
1334e77b-86ce-4784-b613-f1544146c247National Council for Prescription Drug Programs20120724
bf667704-f439-4e8a-a4a5-dd150462a125Doak Dermatologics20070209

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4doxycycline
ATCJ01AATetracyclinesATC1-4doxycycline
FDASPLD013754TetracyclinesCHEMhas_chemical_structuredoxycycline
FDASPLN0000175882Tetracycline-class DrugEPChas_epcdoxycycline
MEDRTD004318DoxycyclineCHEMhas_ingredientdoxycycline hyclate
MEDRTD004318DoxycyclineCHEMhas_ingredientdoxycycline
MEDRTD013752TetracyclineCHEMci_chemclassdoxycycline
MEDRTD013752TetracyclineCHEMci_chemclassdoxycycline hyclate
MEDRTD000881AnthraxDISEASEmay_treatdoxycycline hyclate
MEDRTD000881AnthraxDISEASEmay_treatdoxycycline
MEDRTD002169Campylobacter InfectionsDISEASEmay_treatdoxycycline
MEDRTD002169Campylobacter InfectionsDISEASEmay_treatdoxycycline hyclate
MEDRTD002675Child, PreschoolDISEASEci_withdoxycycline hyclate
MEDRTD002675Child, PreschoolDISEASEci_withdoxycycline
MEDRTD002771CholeraDISEASEmay_treatdoxycycline hyclate
MEDRTD002771CholeraDISEASEmay_treatdoxycycline
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxycycline hyclate
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxycycline
MEDRTD006100Granuloma InguinaleDISEASEmay_treatdoxycycline
MEDRTD006100Granuloma InguinaleDISEASEmay_treatdoxycycline hyclate
MEDRTD008107Liver DiseasesDISEASEci_withdoxycycline hyclate
MEDRTD008107Liver DiseasesDISEASEci_withdoxycycline
MEDRTD008288MalariaDISEASEmay_preventdoxycycline
MEDRTD008288MalariaDISEASEmay_preventdoxycycline hyclate
MEDRTD009175Mycoplasma InfectionsDISEASEmay_treatdoxycycline
MEDRTD009175Mycoplasma InfectionsDISEASEmay_treatdoxycycline hyclate
MEDRTD010930PlagueDISEASEmay_treatdoxycycline
MEDRTD010930PlagueDISEASEmay_treatdoxycycline hyclate
MEDRTD010996Pleural EffusionDISEASEmay_treatdoxycycline hyclate
MEDRTD010996Pleural EffusionDISEASEmay_treatdoxycycline
MEDRTD018410Pneumonia, BacterialDISEASEmay_treatdoxycycline hyclate
MEDRTD018410Pneumonia, BacterialDISEASEmay_treatdoxycycline
MEDRTD011247PregnancyDISEASEci_withdoxycycline hyclate
MEDRTD011247PregnancyDISEASEci_withdoxycycline
MEDRTD009956PsittacosisDISEASEmay_treatdoxycycline hyclate
MEDRTD009956PsittacosisDISEASEmay_treatdoxycycline
MEDRTD012061Relapsing FeverDISEASEmay_treatdoxycycline hyclate
MEDRTD012061Relapsing FeverDISEASEmay_treatdoxycycline
MEDRTD012373Rocky Mountain Spotted FeverDISEASEmay_treatdoxycycline hyclate
MEDRTD012373Rocky Mountain Spotted FeverDISEASEmay_treatdoxycycline
MEDRTD012598SclerosisDISEASEinducesdoxycycline
MEDRTD012598SclerosisDISEASEinducesdoxycycline hyclate
MEDRTD013587SyphilisDISEASEmay_treatdoxycycline hyclate
MEDRTD013587SyphilisDISEASEmay_treatdoxycycline
MEDRTD014141TrachomaDISEASEmay_treatdoxycycline
MEDRTD014141TrachomaDISEASEmay_treatdoxycycline hyclate
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadoxycycline hyclate
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadoxycycline
MEDRTN0000008334Cell Membrane AlterationPEhas_pedoxycycline hyclate
MEDRTN0000008334Cell Membrane AlterationPEhas_pedoxycycline
MEDRTN0000008732Decreased MitosisPEhas_pedoxycycline hyclate
MEDRTN0000008732Decreased MitosisPEhas_pedoxycycline
MEDRTN0000008841Decreased Protein SynthesisPEhas_pedoxycycline hyclate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pedoxycycline

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH50 MG (expressed as doxycycline hyclate)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA062269
CODESANDAANDA062505
CODESANDAANDA062538
CODESANDAANDA210536
CODESVUID4001963
NAMESPrescribable Synonymdoxycycline hyclate 50 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File